ConductScience.org, home

Paper4201876

Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans).

Altman RD and 5 others. N Engl J Med, 1973. Cited by 257 papers, by iCite.

Cite this record

ConductScience Library. Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans). Papers, record 4201876. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4201876

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans).
PubMed
Journal
N Engl J Med
PubMed
Year
1973
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
257
iCite
Relative citation ratio, by iCite
7.83
iCite
Revised in PubMed
2016-11-23
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Altman RDR D
2Johnston CCC C
3Khairi MRM R
4Wellman HH
5Serafini ANA N
6Sankey RRR R

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Organophosphorus CompoundsMajor topic
Osteitis DeformansMajor topic
Administration, Oral
Aged
Alkaline Phosphatase
Bone and Bones
Clinical Trials as Topic
Dose-Response Relationship, Drug
Drug Evaluation
Etidronic Acid
Female
Fluorides
Humans
Hydroxyproline
Isotopes
Male
Middle Aged
Pain
Placebos
Radiography
Strontium Isotopes
Time Factors

Source PubMed

Download CSV of topics

Cited by50

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 257 citations.

PMIDTitleJournalYearIn PapersSource
37198232Targeting strategies for bone diseases: signaling pathways and clinical studies.Signal Transduct Target Ther2023https://conductscience.org/library/papers/37198232PubMed
36288714Genome-wide CRISPR screen reveals v-ATPase as a drug target to lower levels of ALS protein ataxin-2.Cell Rep2022https://conductscience.org/library/papers/36288714PubMed
33312475Therapeutic Dimensions of Bisphosphonates: A Clinical Update.Int J Prev Med2020https://conductscience.org/library/papers/33312475PubMed
32115673Clinical features, diagnosis and treatment of Paget's disease of bone in mainland China: A systematic review.Rev Endocr Metab Disord2020https://conductscience.org/library/papers/32115673PubMed
31848640Management of Paget's disease of bone.Osteoporos Int2020https://conductscience.org/library/papers/31848640PubMed
30803025Diagnosis and Management of Paget's Disease of Bone in Adults: A Clinical Guideline.J Bone Miner Res2019https://conductscience.org/library/papers/30803025PubMed
29192423Bisphosphonates for Paget's disease of bone in adults.Cochrane Database Syst Rev2017https://conductscience.org/library/papers/29192423PubMed
22223192A role for C-terminal cross-linking telopeptide (CTX) level to predict the development of bisphosphonate-related osteonecrosis of the jaws (BRONJ) following oral surgery?Ir J Med Sci2012https://conductscience.org/library/papers/22223192PubMed
21847749Bisphosphonates in the treatment of osteoporosis: a review of their contribution and controversies.Skeletal Radiol2011https://conductscience.org/library/papers/21847749PubMed
21437131Disturbance of inorganic phosphate metabolism in diabetes mellitus: temporary therapeutic intervention trials.Diabetes Metab Syndr Obes2009https://conductscience.org/library/papers/21437131PubMed
19946296Metabolic bone diseases: treating Paget disease: when matters more than how.Nat Rev Rheumatol2009https://conductscience.org/library/papers/19946296PubMed
16937267Guidelines for diagnosis and management of Paget's disease of bone in Japan.J Bone Miner Metab2006https://conductscience.org/library/papers/16937267PubMed
11298188Calcitonin and calcitonin receptors: bone and beyond.Int J Exp Pathol2000https://conductscience.org/library/papers/11298188PubMed
10780527Bisphosphonates induce apoptosis in human breast cancer cell lines.Br J Cancer2000https://conductscience.org/library/papers/10780527PubMed
9820883Bisphosphonates in bone diseases.Pharm World Sci1998https://conductscience.org/library/papers/9820883PubMed
8894359The contribution of Sir James Paget (1814-1894) to the study of rheumatic disease.Clin Rheumatol1996https://conductscience.org/library/papers/8894359PubMed
7521833Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.Drugs1994https://conductscience.org/library/papers/7521833PubMed
7506648Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.Drugs1993https://conductscience.org/library/papers/7506648PubMed
7426385The effects of calcitonin and colchicine on the cellular response to diphosphonate.Br J Exp Pathol1980https://conductscience.org/library/papers/7426385PubMed
7014170Pharmacology and therapeutic use of calcitonin.Drugs1981https://conductscience.org/library/papers/7014170PubMed

See all 50 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4201876

GET https://conductscience.org/api/papers/v1/4201876/cited_by?page=2